Quick Answer
Assyro is our first recommendation to evaluate for a supported FDA eCTD v4.0 preparation and validation workflow. Assyro does not support v3.2.2, so it cannot replace a required v3.2.2 validation operation. For a standalone EURSvalidator replacement, compare LORENZ eValidator ONE or FIVE against your licensed regional sets and reporting needs. Reconfiguring or extending the existing EURSvalidator subscription may be sufficient when the gap is country coverage or selected settings.
A EURSvalidator renewal becomes difficult when “we need another region” turns into “we need another validator.” Those are different decisions. Before comparing software, identify whether the missing capability is unavailable in the product, absent from your subscription, disabled in the configuration or simply missing from the report someone received.
This guide follows that decision from regional requirements to a usable report handoff. Assyro publishes the guide and appears first as our editorial preference. The comparison is based on primary documentation checked September 14, 2026. We have not executed a comparative validator trial. The worked example below is a documentary assessment, with operational proof still required.
Start with the replacement path that matches the gap
| Option | Reason to investigate it | Boundary that changes the decision |
|---|---|---|
| Assyro | Connect preparation and review with supported v4.0 validation | Required v3.2.2 validation is unsupported; other authority profiles need specific proof |
| LORENZ eValidator ONE | Single-user validation across basic profiles | Match the required criteria and outputs; do not assume custom server workflows |
| LORENZ eValidator FIVE | Server operation, extended/custom profiles and batch work | Verify the quoted configuration and translation of any existing custom checks |
| AGES eValidator | Investigate the BASG-hosted validator for an applicable authority workflow | Published Austrian instructions do not establish a global replacement or a commercial support arrangement |
| Retain or reconfigure EURSvalidator | Regional subscription packages can be combined | Confirm whether the required set is licensed, available and actually selected |
ONE and FIVE are editions within one vendor family, not two independent validation engines in a benchmark. The table also separates a supported Assyro workflow from an authority-hosted download. Each candidate needs to satisfy the same required operation before price or convenience decides the outcome.
Establish what your EXTEDO subscription contains
EURSvalidator is EXTEDO's technical validation product for eCTD and NeeS submissions. Its regional subscriptions contain validation sets for the countries or regions being served. A procurement record should therefore identify both the product release and the purchased package, rather than recording only “EXTEDO validation.” EURSvalidator product scope.
Do not confuse EURSvalidator with EURS. EXTEDO describes EURS as an authority-facing validation and review solution with a broader submission-handling role. A joint functionality document can contain capabilities for both products; a feature in an EURS column is not evidence that the same feature is included in EURSvalidator. EXTEDO EURS product information.
The same boundary applies to submission publishing. Replacing the validator does not automatically require replacing EXTEDOpulse Submission Publishing or rebuilding a dossier-authoring environment. Write down which application receives the package, which runs the checks, where the report is stored and who acts on it. That gives the purchase a specific scope.
Regional naming matters commercially. EXTEDO's EURSvalidator product sheet groups France within EU West and Germany within EU Central, among other country packages. Its detailed matrix qualifies EU regional licenses as usable for their licensed countries. A broadly shared EU criteria set should not be treated as permission to validate for every country under a narrower license. Confirm the actual entitlement in your agreement. EURSvalidator regional packages, supported-set matrix.
This is where staying can make sense. If the required country is available through an additional package, compare that arrangement with the cost and work of changing validators. If the product cannot provide a mandatory set, extending the subscription is not a solution. Obtain the distinction in writing.
Assyro: investigate a supported workflow, not an assumed global substitute
Assyro is our first evaluation when the team wants technical checking closer to the people preparing and reviewing the material. Use a supported FDA v4.0 case to see whether a finding can be understood, assigned and corrected without losing the source document context.
Begin with the actual reason for considering a change. If reports arrive late because the package itself is incomplete, a more connected preparation workflow may be relevant. If the problem is a missing country entitlement for a v3.2.2 package, Assyro does not solve that validation requirement today. The replacement scope must reflect that limitation.
In the demonstration, ask the operator to identify the applicable checks and follow one correction into a subsequent run. Then inspect what the publishing or quality colleague receives. The handoff should make the tested package, findings and unfinished work understandable. These are acceptance requirements for the evaluation; this article does not assert that every requested field, export or integration is available.
Keep a required incumbent validator in the operating model when the scope demands it. Complementary use may be appropriate if Assyro improves a supported part of the process and the retained tool continues to perform another necessary operation. Include the extra handoff and license in the comparison so that the proposal remains realistic.
The Assyro validation page supplies the public starting point. Confirm the authority, version and customer-available workflow in the actual demonstration. A general validation claim cannot establish equivalence to EURSvalidator's regional packages, historical report handling or any configured checks your team depends on.
LORENZ eValidator: choose ONE or FIVE by the work being preserved
LORENZ is the direct standalone vendor alternative in this shortlist. eValidator ONE targets a single user working with multiple regions or formats. Its current product description identifies basic profiles covering current and previous validation criteria and a one-year subscription for workstation use. eValidator FIVE adds a server-oriented arrangement, extended profiles, customization, browser task management and a batch-processing client. eValidator ONE, eValidator FIVE.
For an individual operator replacing a regional EURSvalidator subscription, start by mapping each required country, format and criteria revision to the proposed ONE configuration. Ask for a sample of the actual report the colleague receiving the output will use. Do not decide from a generic list of country names: the installed profile and its revision are the purchasing evidence that matters.
For a shared validation function, examine FIVE's operating model. Inventory the work currently performed in batches, the settings that users can change and any organization-specific checks. Then ask how that work is configured, maintained and reviewed in the quoted arrangement. A vendor's ability to customize profiles does not prove automatic conversion of your existing definitions.
LORENZ also offers Basic, but its current instructions require selecting a profile at first use and say that selection cannot subsequently be changed. That can suit a bounded requirement; it is not evidence of a flexible replacement for a subscription covering several distinct profiles. eValidator Basic selection rule.
Keep the publishing products separate. eValidator FIVE is a validator, while docuBridge FIVE is a publisher. Confirm the current name, installed release and licensed features in the proposal. A switch from EURSvalidator to an eValidator edition should preserve the required input, rule coverage and outgoing record before the team considers a wider platform change.
AGES eValidator: assess the published authority workflow carefully
The Austrian BASG website provides an AGES eValidator 25.2 download and a corresponding installation guide dated January 16, 2026. The page also links EU validation criteria v8.2. This is worth investigating for a matching authority workflow, with a much narrower scope than a worldwide commercial subscription. BASG AGES eValidator page.
The page illustrates why the exact document matters. Its introductory installation text still refers to 24.2, while the linked guide identifies 25.2. Use the current linked document and confirm the package version before evaluating it. The 25.2 installation guide identifies its effective date and the installer it describes; we have not downloaded or installed that binary.
Treat this as an authority-hosted option to assess, not proof of a separate independent engine, global profile entitlement or a vendor support contract. Ask whether the published scope covers the exact submission, whether the output satisfies your procedure and who will own updates and assistance. An available download is not a complete operating plan.
For a team whose requirements include FDA validation and several commercial regional profiles, the BASG documentation alone cannot satisfy the whole brief. Keep any unproven profile unresolved. A narrow requirement may make the option worth investigating; a broad requirement may favor retaining EURSvalidator or evaluating a commercial eValidator configuration.
Check selected sets before blaming the engine
A set may be available in the software but absent from a particular run. EXTEDO's functionality matrix describes enabling and disabling validation sets, automatic selection with a NeeS exception, and user choices that persist after upgrades or reinstallation. An updated installation therefore does not, by itself, establish that the intended selection is active. EURSvalidator selection behavior.
Inspect four separate facts: available, licensed, selected and executed. Ask the operator to show the actual settings and completed-run information for the package in question. If one of those facts is missing, the evidence is incomplete even when the report looks familiar.
Also distinguish FAST sets from a complete agreed profile. EXTEDO describes FAST sets as containing a reduced set of criteria. A speed comparison using different check scope cannot establish that one validator is faster at the same job. Define the required coverage first, then compare elapsed time only if the trial records equivalent work.
For NeeS work, confirm the applicable format and selection process explicitly. Software support for a format does not establish that an authority accepts it for your submission type. The validator configuration and the regulatory submission decision are separate responsibilities.
A reproducible documentary comparison of EU and FDA requirements
Consider a synthetic buying scenario: one operator currently uses EURSvalidator, needs EU v3.2.2 validation for work involving France and Germany, and also needs FDA v3.2.2 validation. The publisher will remain unchanged. Each client must receive a detailed report, while the team retains the original run record. This is a requirements example, not a customer history or an executed trial.
The first comparison can be reproduced from the documents linked below. It establishes what the documents support and what still needs proof. It does not certify any candidate's installed software.
| Requirement | Source evidence inspected September 14, 2026 | Documentary outcome |
|---|---|---|
| EU v3.2.2 with EU M1 3.1.1 and criteria 8.2 | EMA's implementation document pairs these versions; EXTEDO's 25.07 matrix contains an EU 8.2 row | A relevant profile is documented; installed revision and licensed countries still need confirmation |
| FDA v3.2.2 using current applicable criteria | FDA lists criteria 4.6; the inspected EXTEDO matrix includes an FDA 4.4 row | Obtain newer release/profile evidence; the older matrix does not establish current coverage |
| France and Germany within the contract | EXTEDO's product sheet places them in different regional packages | Confirm both countries in the purchased arrangement, even where criteria are shared |
| One tool replaces all required v3.2.2 checks | Assyro does not support v3.2.2 | Exclude Assyro from this full-replacement scope; consider it only for a separately supported task |
The EU requirement comes from the June 2025 implementation document for EU M1 3.1.1 and validation criteria 8.2, which identifies December 1, 2025 for their mandatory use in the described v3.2.2 scope. The current EMA eCTD page retains that version pairing. Do not transfer this row to eCTD v4.0. EU implementation document, EMA eCTD v3.2.2 information.
For the FDA row, the current standards index identifies validation criteria 4.6, with support beginning August 28, 2026. The EXTEDO document currently linked from its product page is titled EURS 8.0 and EURSvalidator 25.07 — Supported Validation Sets and Functionality. These identifiers refer to different things: package standard, agency criteria and product release. FDA criteria index, EXTEDO matrix.
The gap is documentary. It does not establish that the currently offered EURSvalidator release lacks FDA 4.6 support. Ask EXTEDO for the matching current release and profile information, then require it in the operational evaluation. Apply the same evidence standard to LORENZ or any other proposed replacement.
To repeat this assessment later, save the document title and revision, checked date, relevant row or passage, proposed license and the resulting status. A replacement is not eligible merely because its product page says “FDA” or “EU.” Its required rows must be supported by the actual offered configuration.
Specify the report each person needs
EXTEDO distinguishes short and long PDF reports: the short report contains detected errors; the long report also contains warnings and detailed information. Its product information describes automatic saving of a report or summary. These are useful outputs to preserve when evaluating a replacement. EURSvalidator report options.
Define two roles in the handoff. The operator needs enough detail to locate and correct a finding. The person accepting the package needs to know what was checked, which issues remain and whether the result belongs to the package they received. Giving both people a short report without explaining its scope can create an avoidable misunderstanding.
Keep the original exported report, the package identifier and the selected settings together. Add your team's disposition in a separate record so that the original rule description and severity remain available. Record the person accepting any unresolved issue and the basis for that decision; do not silently convert a warning into a pass.
When comparing reports from different tools, align the input and enabled criteria before comparing counts. A different report filter, additional best-practice checks or an incomplete run can change what appears. Ask for a plain account of checks not performed and outputs omitted. Technical validation remains distinct from scientific review, gateway delivery and the authority's final acceptance decision.
Demonstrate the missing-set failure before approving a switch
After documentary screening, require an operational demonstration using a legally usable package and agreed expected outcomes. Record the software release, criteria revision, license configuration, input identity and run date. The demonstration should show the required set running, its report being retrieved and a correction being traced into a later run.
Then change one condition: ask for an authority-specific set that the proposed configuration does not contain. A satisfactory evaluation must make that absence clear. An unperformed check cannot count as passed. If the set can be added, document the added entitlement and repeat the required operation. If the candidate cannot supply it, exclude the candidate from that scope.
Distinguish this from a set that is installed but deselected. In that case, correct the selection through the authorized process and repeat the run; do not use the first incomplete assessment as the final evidence. The record should let a second operator understand why a new run was necessary.
Finally, check the report handoff with the receiving colleague. Have that person identify the exact package, selected scope and unresolved findings without relying on the original operator's memory. These are proposed acceptance exercises. No candidate is represented here as having passed them, and no executable fixture or vendor output is supplied by this article.
Cost the transition and the option to stay
Request proposals against the same country list, formats, workload and reporting requirements. Include the licenses or subscriptions, required profiles, support, setup, verification, training and internal administration. For a server option, include the work of configuring access and maintaining it. For an authority-hosted download, include the people responsible for installation, updates and support escalation.
Preserve the historical evidence before retiring the incumbent. Identify where old reports, input packages and dispositions will remain accessible. Ask whether a proposed importer preserves those relationships; compatibility is unresolved until demonstrated. A folder of readable PDFs may meet one retrieval requirement while failing another that depends on searchable run metadata.
Compare three realistic choices: renew the required existing package, adjust its entitlements or configuration, and switch to an eligible alternative. Count incumbent overlap once and retain archive costs for as long as needed. Do not record a saving for a license the team must keep using. The eCTD software cost guide provides a broader basis for comparing the same operating scope.
Staying is reasonable when the current product meets the required checks and a settings, report or entitlement adjustment resolves the problem. Switching is stronger when the alternative demonstrates a meaningful improvement while preserving every mandatory operation and record. A lower quote with a missing authority set is an incomplete proposal.
Bring the country list, current package, criteria revisions and one representative report to the next vendor discussion. For a supported Assyro use case, request a validation-workflow discussion. The useful outcome is a clear decision about what can move, what must remain and which requirement still needs evidence.
About the author
Assyro Team
Expert regulatory operations consultants helping pharmaceutical companies navigate complex compliance challenges.

